Managing mental health in pregnancy
Polycystic Ovarian Syndrome

Ovarian Hyperstimulation syndrome

Olorunfunmi Bankole Odusoga MRCOG

Table of content

1. Definition

2. Incidence

3. Diagnosis

4. Pathophysiology

5. Classification of severity

6. Risk management

8. Management

9. Prevention

10. Reference

Definition:

Systemic disease resulting from vasoactive products released by hyperstimulated ovaries.

Incidence

Mild OHSS 33% of IVF

Moderate to severe 3-8%

Risk Factors
  • Young women
  • Women with PCOS
  • Multiple pregnancy
  • Previous OHSS
  • Low body weight
  • Diabetes Mellitus
  • Exposure to HCG ,as trigger or luteal support
  • Use of GnRH analogue as opposed to GNRH antagonist
  • High Dose gonadotrophin stimulation regimen
  • High follicular phase LH
  • Multiple follicular response with stimulation
  • High serum oestradiol levels during treatment >20000p/mol

Diagnosis
  • History of ovarian stimulation, either by gonadotrophins or anti-estrogen, followed by the typical symptoms of abdominal distension, abdominal pain, nausea and vomiting
Differential Diagnosis
  • Ovarian cyst / torsion / haemorrhage
  • Pelvic infection
  • Intra-abdominal haemorrhage
  • Ectopic pregnancies
  • Appendicitis

Pathophysiology
  • Increased capillary permeability
  • Leakage of fluid from vascular component
  • Third space fluid accumulation
  • Intravascular dehydration

Classification Of Severity of OHSS
Grade            Symptoms
Mild Abdominal bloating, mild abdominal pain, ovarian size usually <8cm
Moderate Moderate abdo pain, nausea+/-vomiting, USS evidence of ascites, ovarian size 8-12cm
Severe Clinical ascites, oliguria, haemoconcentration haematocrit >45%,hypoprotenaemia,Ovarian size usually >12cm
Critical Tense ascites or large hydrothorax,Haematocrit>55%, WCC>25000,Oligo/anuria,VTE,Adult Respiratory Distress Syndrome

Risk Management
  • Assesement and documetation of severity of OHSS
  • OHSS related deaths must be reported to the Confidential enquiries into maternal death, irrespective of whether woman was pregnant
  • Assisted conception units should provide written information including risks, symptoms of OHSS, actions to take ,24hrs contact no and access to clinician with necessary expertise.
  • Agreed protocols should be made available by assisted conception units to GPs,Gynaecology departments and Emergency department

Management

Assessment

  • Body weight, abdominal girth measurement, and pelvic USS to measure ovarian size and check for ascites
  • Lab Investigation: FBC, Haematocrit, serum creatinine and electrolyte, LFT

Outpatient Management
  • Treatment of mild and moderate OHSS can be managed on an outpatient basis
  • Analgesia-Paracetamol,Codeine,Avoid NSAIDS
  • Drink to thirst, rather than to excess
  • Avoid strenuous exercise and sexual intercourse to prevent injury or torsion to hyperstimulated ovaries
  • Women should continue progesterone luteal support but HCG luteal support is inappropriate
  • Review every 2-3days
  • Prolonged monitoring if woman conceives

Inpatient Admission
History & exam Pain, breathlessness, hydration, weight, CVS,Heart Rate,BP, Abdominal girth, ascites, intake and output chart
Investigations FBC, Hb,Hematocrit, WCC, E/u+Cr,LFT,Clotting,Pelvic USS,Chest Xray or USS,ECG and Echocardiogram If suspecting Pericardial effusion

  • Admit patient with severe OHSS, keep under review until resolution of the condition
  • Admit moderate OHSS who are unable to control their pain or nausea with oral treatment.
  • Multidisciplinary assistance in critical or severe OHSS with persistent haemo-concentration and dehydration
  • Doctor with experience with OHSS should remain in overall charge
  • Management is majorly supportive

Symptom Relief:
  • Analgesia,Paracetamol ,opiates avoid Nsaids, Antiemetics
  • Assess woman daily and more frequently in critical OHSS
  • Check abdominal girth, hydration,cardiorespiratory system
  • Abdominal exams to look for degree of distension, palpable ovaries, presence or absence of ascites and paralytic ileus

  • Monitor fluid input and output daily, urine output of less than 1000mls/day or a persistent positive fluid balance is a cause for concern
  • Allow women to drink to thirst
  • Invasive monitoring should be discussed with anaesthetist in severe OHSS with persistent oliguria and haemoconcentration despite initial colloid volume expansion
  • Avoid Diuretics as it depletes intravascular volume(may have a role with careful haemodynamic monitoring in cases where oliguria persists despite adequate intravascular volume expansion and a normal intraabdominal pressure)
  • Women with haemoconcentration,HB>14g/dl,haematocrit>45% may need intensive initial rehydration such as 1L of saline over 1hr
  • Try Colloids if urine output is less than 0.5ml/kg/hr and patient is haemoconcentrated
  • If Oliguria and haemoconcentration persists try paracentesis

Management Of Ascites
  • Paracentesis under USS guidance if persistent oliguria despite adequate fluid replacement
  • Consider intravenous colloid replacement after drainage of large ascitic fluid.
Thrombosis
  • Routine screening in women undergoing assisted conception is not warranted
  • Thrombophylaxis should be provided for all women admitted for OHSS until discharge and possibly longer depending on other risk factors
  • Incidence of VTE in OHSS 0.7-10%
  • Unusual neurological symptoms following ovarian stimulation think of thrombotic episode in an uncommon location and refer for appropriate expert opinion.

Pelvic Surgery
  • Restricted to adnexal torsion or co-incident problems requiring surgery
Reassurance
  • Pregnancy may continue despite OHSS and no increased risk of congenital abnormalities

Prevention

There are some strategies that can be employed to lower the incidence or severity of OHSS occurring. These include:

  • Using low-dose stimulation protocols, or natural cycle IVF
  • Follicular monitoring
  • Utilising GnRH antagonist cycles rather than GnRH analogues
  • Utilising progesterone instead of HCG for luteal suppot
  • Abandoning ART cycles prior to HCG administration and oocyte collection
  • Delaying embryo transfer following collection and elective freezing of all embryos
  • Coasting, whereby the HCG trigger is withheld until serum estradiol levels have returned to acceptable levels
  • GnRH agonist triggering the final maturation of oocytes, but pregnancy rates are reduced

Reference